View ValuationAlbemarle 향후 성장Future 기준 점검 4/6Albemarle (는) 각각 연간 41.6% 및 6.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 39.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12% 로 예상됩니다.핵심 정보41.6%이익 성장률39.91%EPS 성장률Chemicals 이익 성장42.1%매출 성장률6.9%향후 자기자본이익률11.97%애널리스트 커버리지Good마지막 업데이트07 May 2026최근 향후 성장 업데이트공지 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.공지 • May 03Albemarle Corporation Reaffirms Earnings Guidance for the Year 2024Albemarle Corporation reaffirmed earnings guidance for the year 2024. For the period, the company expects net sales of $5.5 billion to $6.2 billion.공지 • Nov 02Albemarle Corporation Revises Net Sales Guidance for the Full Year 2023Albemarle Corporation revised net sales guidance for the full year 2023. For the year, the company now expects net sales to be in the range of $9.5 billion to $9.8 billion against previous guidance of $10.4 billion to $11.5 billion.모든 업데이트 보기Recent updates공지 • 22hAlbemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.공지 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026공지 • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.공지 • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States공지 • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.공지 • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.공지 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.공지 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026공지 • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.Upcoming Dividend • Dec 05Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 12 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.5%).Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.공지 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.Declared Dividend • Nov 03Second quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 12th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.7%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공지 • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.공지 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025Upcoming Dividend • Sep 05Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 01 October 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.2%).공지 • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.공지 • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.Declared Dividend • Jul 28First quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 12th September 2025 Payment date: 1st October 2025 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공지 • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).Buy Or Sell Opportunity • Jun 24Now 25% overvaluedOver the last 90 days, the stock has fallen 25% to €52.40. The fair value is estimated to be €41.98, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.공지 • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025Upcoming Dividend • Jun 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 June 2025. Payment date: 01 July 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (4.0%).Declared Dividend • May 12First quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 13th June 2025 Payment date: 1st July 2025 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공지 • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.Reported Earnings • May 02First quarter 2025 earnings released: US$0.003 loss per share (vs US$0.078 loss in 1Q 2024)First quarter 2025 results: US$0.003 loss per share (improved from US$0.078 loss in 1Q 2024). Revenue: US$1.08b (down 21% from 1Q 2024). Net loss: US$340.0k (loss narrowed 96% from 1Q 2024). Profit margin: 0% (up from net loss in 1Q 2024). Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 24 percentage points per year, which is a significant difference in performance.공지 • Apr 03Albemarle Corporation to Report Q1, 2025 Results on Apr 30, 2025Albemarle Corporation announced that they will report Q1, 2025 results After-Market on Apr 30, 2025공지 • Mar 29Albemarle Corporation, Annual General Meeting, May 06, 2025Albemarle Corporation, Annual General Meeting, May 06, 2025. Location: 4250 congress street, nc 28209, charlotte, United States공지 • Mar 24Albemarle Corporation(NYSE:ALB) dropped from FTSE All-World Index (USD)Albemarle Corporation(NYSE:ALB) dropped from FTSE All-World Index (USD)Declared Dividend • Mar 03Fourth quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 14th March 2025 Payment date: 1st April 2025 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공지 • Feb 28Albemarle Corporation Announces Quarterly Common Stock Dividend, Payable on April 1, 2025The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2025, to shareholders of record at the close of business as of March 14, 2025.Reported Earnings • Feb 13Full year 2024 earnings released: US$11.20 loss per share (vs US$13.41 profit in FY 2023)Full year 2024 results: US$11.20 loss per share (down from US$13.41 profit in FY 2023). Revenue: US$5.38b (down 44% from FY 2023). Net loss: US$1.32b (down 184% from profit in FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.공지 • Jan 10Albemarle Corporation to Report Q4, 2024 Results on Feb 12, 2025Albemarle Corporation announced that they will report Q4, 2024 results After-Market on Feb 12, 2025Upcoming Dividend • Dec 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 December 2024. Payment date: 02 January 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.9%). Lower than average of industry peers (5.5%).Reported Earnings • Nov 07Third quarter 2024 earnings released: US$9.45 loss per share (vs US$2.58 profit in 3Q 2023)Third quarter 2024 results: US$9.45 loss per share (down from US$2.58 profit in 3Q 2023). Revenue: US$1.35b (down 41% from 3Q 2023). Net loss: US$1.11b (down 467% from profit in 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 26% per year, which means it is performing significantly worse than earnings.공지 • Oct 07Albemarle Corporation Announces Executive ChangesAlbemarle Corporation announced the company’s new operating structure to adapt to dynamic market conditions. As part of this change, effective Nov. 1, 2024: Specialties Business President Netha Johnson will become chief operations officer and continues to report to Chairman and CEO Kent Masters. In this role, he will lead global manufacturing, research and technology, capital projects and process chemistry execution. Johnson joined Albemarle in 2018 and has more than 25 years of experience in global manufacturing, leadership and general management. Energy Storage Business President Eric Norris will become chief commercial officer and continues to report to Masters. In this role, he will oversee enterprise product management, sales and commercial excellence. Norris joined Albemarle in 2018 and has more than 25 years of experience in strategy, corporate development and general management. In addition, the following leaders will report to Masters: Melissa Anderson will become chief transformation officer, effective Nov. 1, which reflects her current oversight of people, strategy and transformation; Stacy Grant will become general counsel, corporate secretary and chief compliance officer, effective immediately, and succeeds Kristin Coleman, who is leaving the company. Grant joined Albemarle in 2023 and previously served as vice president & deputy general counsel, global corporate affairs; Mark Mummert will become chief capital, resources and integrated supply chain officer, effective Nov. 1, which includes expanded responsibility for resources, joint venture management, customer service and operational excellence. On October 7, 2024, in connection with the implementation of the new operating structure described in Item 7.01 below, Kristin Coleman will cease serving as Executive Vice President, General Counsel and Corporate Secretary of the Company and her last day of employment will be November 4, 2024. In addition, in connection with the implementation of such new operating structure, John C. Barichivich III will cease serving as Vice President, Corporate Controller and Chief Accounting Officer of the company effective upon the appointment of his successor, and his last day of employment will be December 31, 2024.공지 • Oct 01Albemarle Corporation to Report Q3, 2024 Results on Nov 06, 2024Albemarle Corporation announced that they will report Q3, 2024 results After-Market on Nov 06, 2024New Risk • Sep 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).Upcoming Dividend • Sep 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 September 2024. Payment date: 01 October 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.2%).공지 • Aug 13Albemarle Reportedly May Look to Offload 49% Stake in Greenbushes Lithium Mine to IGOSpeculation is mounting that US-based Albemarle Corporation (NYSE:ALB) may be considering selling down its 49% stake in the Greenbushes lithium mine to its Australian-listed partner IGO Limited (ASX:IGO), after the world's largest lithium producer this month slashed jobs and shut part of a processing facility in Western Australia. Greenbushes in WA is a global standout, and there is scepticism about the market chatter, although IGO wants to buy more of the asset should it be available, say sources. IGO did not comment. One reason a sale may be on the table is that Greenbushes does not qualify for the Inflation Reduction Act benefits in the US because of its partial Chinese ownership of 25.1%. To quality, Chinese ownership would need to be 24.9% or less, although the US government may show some leniency. IGO and China's Tianqi both own 51% in a joint venture arrangement. US-based lithium specialist Albemarle owns the remainder. The Australian reported last month that Albemarle, Tianqi and IGO would be taking the brakes off the giant Greenbushes mine despite low lithium prices, with the mine set to lift production over the next year as IGO intensifies its hunt for growth opportunities.Reported Earnings • Aug 02Second quarter 2024 earnings released: US$1.96 loss per share (vs US$5.54 profit in 2Q 2023)Second quarter 2024 results: US$1.96 loss per share (down from US$5.54 profit in 2Q 2023). Revenue: US$1.43b (down 40% from 2Q 2023). Net loss: US$229.9m (down 135% from profit in 2Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.공지 • Jul 02Albemarle Corporation to Report Q2, 2024 Results on Jul 31, 2024Albemarle Corporation announced that they will report Q2, 2024 results After-Market on Jul 31, 2024Upcoming Dividend • Jun 07Upcoming dividend of US$0.40 per shareEligible shareholders must have bought the stock before 14 June 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 58% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (5.1%).공지 • May 03Albemarle Corporation Reaffirms Earnings Guidance for the Year 2024Albemarle Corporation reaffirmed earnings guidance for the year 2024. For the period, the company expects net sales of $5.5 billion to $6.2 billion.Reported Earnings • May 02First quarter 2024 earnings released: US$0.078 loss per share (vs US$10.57 profit in 1Q 2023)First quarter 2024 results: US$0.078 loss per share (down from US$10.57 profit in 1Q 2023). Revenue: US$1.36b (down 47% from 1Q 2023). Net loss: US$9.14m (down 101% from profit in 1Q 2023). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.공지 • Apr 07Albemarle Corporation to Report Q1, 2024 Results on May 01, 2024Albemarle Corporation announced that they will report Q1, 2024 results After-Market on May 01, 2024공지 • Mar 13Albemarle Corporation, Annual General Meeting, May 07, 2024Albemarle Corporation, Annual General Meeting, May 07, 2024, at 07:00 Eastern Standard Time. Location: Albemarle Corporation, 4250 Congress Street, Charlotte, North Carolina 28209, Charlotte North Carolina United States Agenda: To consider and Elect the ten nominees; to approve, on a non-binding advisory basis, the compensation of named executive officers; to approve an amendment to Albemarle's Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock; to ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.Upcoming Dividend • Mar 07Upcoming dividend of US$0.40 per shareEligible shareholders must have bought the stock before 14 March 2024. Payment date: 01 April 2024. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (5.1%). Lower than average of industry peers (5.9%).Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €128, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in Germany. Total returns to shareholders of 10% over the past three years.Reported Earnings • Feb 15Full year 2023 earnings released: EPS: US$13.41 (vs US$22.97 in FY 2022)Full year 2023 results: EPS: US$13.41 (down from US$22.97 in FY 2022). Revenue: US$9.62b (up 31% from FY 2022). Net income: US$1.57b (down 42% from FY 2022). Profit margin: 16% (down from 37% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.공지 • Jan 19Albemarle Reportedly Selling Out of LiontownAlbemarle Corporation (NYSE:ALB) has appointed brokers to sell its stake in Liontown Resources Limited (ASX:LTR), three months after Hancock Prospecting effectively blocked its $6.6 billion takeover bid. JP Morgan was looking to sell Albemarle's 4% stake after the market closed, at prices ranging from $1.26 per share to $1.32 per share. With Albemarle holding 96 million Liontown shares, the deal will be worth about $125 million. The planned sale will be at a loss for Albemarle, which was understood to have acquired its stake at an average entry price of $2.35 per share. Albemarle attempted four times to acquire Liontown, which is developing the Kathleen Valley lithium mine in the Goldfields. The mine would have provided a new supply for Albemarle's downstream processing operations, including its lithium refinery at Kemerton in the South West. It lodged indicative proposals at $2.20 per share in October 2022, $2.35 in March 2023 and $2.50 later that month. It appeared to have succeeded in September when the Liontown board backed its fourth proposal - a takeover bid priced at $3 per share. However Australia's richest person, Gina Rinehart, ended the party after her private company Hancock Prospecting acquired a 19.9% blocking stake. Albemarle scrapped its takeover bid in mid-October, triggering a collapse in Liontown's share price and forcing the company to complete an equity and debt raising to ensure it could complete construction at Kathleen Valley. Hancock has retained its 19.9% stake but has been silent on its intentions.공지 • Jan 12Albemarle Corporation to Report Q4, 2023 Results on Feb 14, 2024Albemarle Corporation announced that they will report Q4, 2023 results After-Market on Feb 14, 2024Upcoming Dividend • Dec 07Upcoming dividend of US$0.40 per share at 1.4% yieldEligible shareholders must have bought the stock before 14 December 2023. Payment date: 02 January 2024. Payout ratio is a comfortable 5.6% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (5.2%). Lower than average of industry peers (6.0%).공지 • Nov 18Albemarle Corporation Announces the Promotion of Cynthia Lima as Senior Vice President, Chief External Affairs and Communications OfficerAlbemarle Corporation announced that Cynthia Lima has been promoted to senior vice president, chief external affairs and communications officer. Lima joined Albemarle early in 2023 as chief communications officer and has expanded her remit to include the global external affairs function. She brings extensive government affairs and communications experience spanning both public and private sectors. Prior to joining Albemarle, Lima founded a communications and public affairs consultancy and held senior positions at domestic and global public relations agencies. Previously, Lima served in the U.S. Department of State and U.S. Department of Veterans Affairs where she was a senate-confirmed presidential appointee. Lima is based in the company's Charlotte, N.C., headquarters and will report to Masters as part of Albemarle's Executive Leadership Team.Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$2.58 (vs US$7.66 in 3Q 2022)Third quarter 2023 results: EPS: US$2.58 (down from US$7.66 in 3Q 2022). Revenue: US$2.31b (up 11% from 3Q 2022). Net income: US$302.5m (down 66% from 3Q 2022). Profit margin: 13% (down from 43% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.공지 • Nov 02Albemarle Corporation Revises Net Sales Guidance for the Full Year 2023Albemarle Corporation revised net sales guidance for the full year 2023. For the year, the company now expects net sales to be in the range of $9.5 billion to $9.8 billion against previous guidance of $10.4 billion to $11.5 billion.공지 • Oct 28Albemarle Corporation Announces CFO Changes, Effective on November 6, 2023Albemarle Corporation announced that Neal Sheorey will join Albemarle as its chief financial officer, effective Nov. 6, 2023. Scott Tozier, Albemarle's current chief financial officer, will transition from his current role and become a strategic advisor to the CEO. Sheorey joins Albemarle from Dow, a global materials science company, where he served for more than 20 years in progressive finance, business, and corporate leadership roles. Most recently, he was vice president of Dow's Coatings & Performance Monomers business unit, a global portfolio with more than $4 billion in sales, where he was responsible for the group's strategy, profitability, and growth initiatives. Prior to his current role, Sheorey served as Dow's vice president of investor relations, senior director of corporate development and global finance director for the Chemicals business group. Sheorey holds a master's degree in business administration with a concentration in finance and corporate strategy from the University of Michigan, and a bachelor's degree in chemical engineering from Northwestern University. Tozier joined Albemarle in 2011 as senior vice president and chief financial officer.공지 • Oct 27Albemarle Corporation Announces Executive Changes, Effective on November 6, 2023Albemarle Corporation announced that Neal Sheorey will join Albemarle as its executive vice president, effective Nov. 6, 2023. Scott Tozier, Albemarle's current executive vice president will transition from his current role and become a strategic advisor to the CEO. Sheorey joins Albemarle from Dow, a global materials science company, where he served for more than 20 years in progressive finance, business, and corporate leadership roles. Most recently, he was vice president of Dow's Coatings & Performance Monomers business unit, a global portfolio with more than $4 billion in sales, where he was responsible for the group's strategy, profitability, and growth initiatives. Prior to his current role, Sheorey served as Dow's vice president of investor relations, senior director of corporate development and global finance director for the Chemicals business group. Sheorey holds a master's degree in business administration with a concentration in finance and corporate strategy from the University of Michigan, and a bachelor's degree in chemical engineering from Northwestern University. Tozier joined Albemarle in 2011 as senior vice president and chief financial officer.공지 • Oct 20Albemarle Corporation (NYSE:ALB) completed the acquisition of additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN)Albemarle Corporation (NYSE:ALB) entered into binding agreement to acquire additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN) on February 23, 2023. As of July 19, 2023, Albemarle Corporation amend the terms of the transaction and agreed to acquire remaining 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources for approximately AUD 590 million ($400 million). Albemarle will supply MinRes’ 15% share of spodumene concentrate for use by Kemerton from the Greenbushes mine. MinRes will pay the benchmark price for its share of Greenbushes spodumene concentrate. In similar transaction Albemarle Corporation entered into binding agreement ownership of the Wodgina mine to change from 60% and 40% to 50% and50%. Albemarle is expected to pay MinRes a completion adjustment currently estimated to be AUD 150 million. As of July 19, 2023, upon closing, Albemarle expects to pay Mineral Resources $380 (AUD 557.5 million) - $400 million (AUD 586.9 million) which includes net consideration for the remaining 15% ownership of Kemerton as well as EED settlement adjustments. Actual settlement adjustments will depend on the date of close. The acquisition is subject to regulatory approvals. The parties anticipate closing the amended arrangements later this year. As of August 2, 2023, the transaction is expected to close in the second half of 2023. Herbert Smith Freehills LLP acted as legal advisor to Kemerton Lithium Hydroxide Plant. Albemarle Corporation (NYSE:ALB) completed the acquisition of additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN) on October 18, 2023.공지 • Oct 16Albemarle Withdraws Non-Binding Offer to Acquire Liontown ResourcesOn October 15, 2023, Albemarle Corporation (NYSE:ALB) announced that it will not pursue a binding agreement to purchase Liontown Resources Limited (ASX:LTR) and has formally withdrawn its non-binding offer to Liontown's board of directors. The decision comes as Albemarle nears the end of its exclusive due diligence process. "Our engagement with the Liontown team has been meaningful and productive. We appreciate the level of cooperation we have received, and we thank the entire team for their efforts," said Kent Masters, Chief Executive Officer of Albemarle. "That said, moving forward with the acquisition, at this time, is not in Albemarle's best interests." The company noted growing complexities associated with the proposed transaction as a factor in its decision. The announcement is consistent with Albemarle's disciplined approach to capital allocation and the company will continue to execute its long-term growth strategy. Planned expansions to deliver volumetric growth continue to progress across the company's global portfolio. Albemarle's capital allocation priorities remain investing in high-return organic and inorganic growth, maintaining its financial flexibility and investment grade credit rating, and funding its dividends. Albemarle is one of Australia's biggest lithium investors, with mining assets at Wodgina and Greenbushes, and with the Kemerton lithium hydroxide plant, which is currently undergoing a significant expansion.Board Change • Oct 13Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.이익 및 매출 성장 예측XTRA:AMC - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20286,2222,0506801,8281112/31/20276,0261,4241,0981,6061712/31/20265,7931,2771,1451,931183/31/20265,495-4005751,081N/A12/31/20255,143-6776921,282N/A9/30/20254,946-188114891N/A6/30/20254,993-1,096-185763N/A3/31/20255,094-1,307-1471,137N/A12/31/20245,378-1,316-993688N/A9/30/20246,502-1,967-1,428594N/A6/30/20247,458-554-1,269996N/A3/31/20248,398326-1,611702N/A12/31/20239,6171,573-8281,327N/A9/30/20239,8823,3244652,376N/A6/30/20239,6633,9189642,642N/A3/31/20238,7733,6759772,423N/A12/31/20227,3202,6906461,908N/A9/30/20225,5931,554-308809N/A6/30/20224,332264-1,04119N/A3/31/20223,626281-613392N/A12/31/20213,328124-609344N/A9/30/20213,313212-54828N/A6/30/20213,229703148977N/A3/31/20213,219364-14802N/A12/31/20203,129376-52799N/A9/30/20203,242382-29835N/A6/30/20203,375438-127728N/A3/31/20203,496507-31820N/A12/31/20193,589533N/A719N/A9/30/20193,519572N/A515N/A6/30/20193,417547N/A522N/A3/31/20193,385695N/A480N/A12/31/20183,375694N/A546N/A9/30/20183,311346N/A606N/A6/30/20183,288335N/A582N/A3/31/20183,172135N/A343N/A12/31/20173,07255N/A304N/A9/30/20172,911315N/A356N/A6/30/20172,810302N/A428N/A3/31/20172,742282N/A645N/A12/31/20162,677442N/A736N/A9/30/20162,703560N/A498N/A6/30/20162,742510N/A480N/A3/31/20162,791468N/A488N/A12/31/20152,826302N/A361N/A9/30/20152,702124N/A379N/A6/30/20152,652149N/A331N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: AMC 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(1.9%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: AMC (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: AMC 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: AMC 의 수익(연간 6.9%)이 German 시장(연간 6.4%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: AMC 의 수익(연간 6.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: AMC의 자본 수익률은 3년 후 12%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 14:38종가2026/05/07 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Albemarle Corporation는 36명의 분석가가 다루고 있습니다. 이 중 18명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관William SeleskyArgus Research CompanyBenjamin KalloBairdAndres Castanos-MollorBerenberg33명의 분석가 더 보기
공지 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.
공지 • May 03Albemarle Corporation Reaffirms Earnings Guidance for the Year 2024Albemarle Corporation reaffirmed earnings guidance for the year 2024. For the period, the company expects net sales of $5.5 billion to $6.2 billion.
공지 • Nov 02Albemarle Corporation Revises Net Sales Guidance for the Full Year 2023Albemarle Corporation revised net sales guidance for the full year 2023. For the year, the company now expects net sales to be in the range of $9.5 billion to $9.8 billion against previous guidance of $10.4 billion to $11.5 billion.
공지 • 22hAlbemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.
공지 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026
공지 • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.
공지 • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States
공지 • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.
공지 • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.
공지 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.
공지 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026
공지 • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.
Upcoming Dividend • Dec 05Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 12 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.5%).
Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
공지 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.
Declared Dividend • Nov 03Second quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 12th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.7%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공지 • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.
공지 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025
Upcoming Dividend • Sep 05Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 12 September 2025. Payment date: 01 October 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.2%).
공지 • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.
Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.
공지 • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.
Declared Dividend • Jul 28First quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 12th September 2025 Payment date: 1st October 2025 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공지 • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.
New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
Buy Or Sell Opportunity • Jun 24Now 25% overvaluedOver the last 90 days, the stock has fallen 25% to €52.40. The fair value is estimated to be €41.98, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.
공지 • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025
Upcoming Dividend • Jun 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 June 2025. Payment date: 01 July 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (4.0%).
Declared Dividend • May 12First quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 13th June 2025 Payment date: 1st July 2025 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공지 • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.
Reported Earnings • May 02First quarter 2025 earnings released: US$0.003 loss per share (vs US$0.078 loss in 1Q 2024)First quarter 2025 results: US$0.003 loss per share (improved from US$0.078 loss in 1Q 2024). Revenue: US$1.08b (down 21% from 1Q 2024). Net loss: US$340.0k (loss narrowed 96% from 1Q 2024). Profit margin: 0% (up from net loss in 1Q 2024). Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 24 percentage points per year, which is a significant difference in performance.
공지 • Apr 03Albemarle Corporation to Report Q1, 2025 Results on Apr 30, 2025Albemarle Corporation announced that they will report Q1, 2025 results After-Market on Apr 30, 2025
공지 • Mar 29Albemarle Corporation, Annual General Meeting, May 06, 2025Albemarle Corporation, Annual General Meeting, May 06, 2025. Location: 4250 congress street, nc 28209, charlotte, United States
공지 • Mar 24Albemarle Corporation(NYSE:ALB) dropped from FTSE All-World Index (USD)Albemarle Corporation(NYSE:ALB) dropped from FTSE All-World Index (USD)
Declared Dividend • Mar 03Fourth quarter dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 14th March 2025 Payment date: 1st April 2025 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공지 • Feb 28Albemarle Corporation Announces Quarterly Common Stock Dividend, Payable on April 1, 2025The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2025, to shareholders of record at the close of business as of March 14, 2025.
Reported Earnings • Feb 13Full year 2024 earnings released: US$11.20 loss per share (vs US$13.41 profit in FY 2023)Full year 2024 results: US$11.20 loss per share (down from US$13.41 profit in FY 2023). Revenue: US$5.38b (down 44% from FY 2023). Net loss: US$1.32b (down 184% from profit in FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.
공지 • Jan 10Albemarle Corporation to Report Q4, 2024 Results on Feb 12, 2025Albemarle Corporation announced that they will report Q4, 2024 results After-Market on Feb 12, 2025
Upcoming Dividend • Dec 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 December 2024. Payment date: 02 January 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.9%). Lower than average of industry peers (5.5%).
Reported Earnings • Nov 07Third quarter 2024 earnings released: US$9.45 loss per share (vs US$2.58 profit in 3Q 2023)Third quarter 2024 results: US$9.45 loss per share (down from US$2.58 profit in 3Q 2023). Revenue: US$1.35b (down 41% from 3Q 2023). Net loss: US$1.11b (down 467% from profit in 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 26% per year, which means it is performing significantly worse than earnings.
공지 • Oct 07Albemarle Corporation Announces Executive ChangesAlbemarle Corporation announced the company’s new operating structure to adapt to dynamic market conditions. As part of this change, effective Nov. 1, 2024: Specialties Business President Netha Johnson will become chief operations officer and continues to report to Chairman and CEO Kent Masters. In this role, he will lead global manufacturing, research and technology, capital projects and process chemistry execution. Johnson joined Albemarle in 2018 and has more than 25 years of experience in global manufacturing, leadership and general management. Energy Storage Business President Eric Norris will become chief commercial officer and continues to report to Masters. In this role, he will oversee enterprise product management, sales and commercial excellence. Norris joined Albemarle in 2018 and has more than 25 years of experience in strategy, corporate development and general management. In addition, the following leaders will report to Masters: Melissa Anderson will become chief transformation officer, effective Nov. 1, which reflects her current oversight of people, strategy and transformation; Stacy Grant will become general counsel, corporate secretary and chief compliance officer, effective immediately, and succeeds Kristin Coleman, who is leaving the company. Grant joined Albemarle in 2023 and previously served as vice president & deputy general counsel, global corporate affairs; Mark Mummert will become chief capital, resources and integrated supply chain officer, effective Nov. 1, which includes expanded responsibility for resources, joint venture management, customer service and operational excellence. On October 7, 2024, in connection with the implementation of the new operating structure described in Item 7.01 below, Kristin Coleman will cease serving as Executive Vice President, General Counsel and Corporate Secretary of the Company and her last day of employment will be November 4, 2024. In addition, in connection with the implementation of such new operating structure, John C. Barichivich III will cease serving as Vice President, Corporate Controller and Chief Accounting Officer of the company effective upon the appointment of his successor, and his last day of employment will be December 31, 2024.
공지 • Oct 01Albemarle Corporation to Report Q3, 2024 Results on Nov 06, 2024Albemarle Corporation announced that they will report Q3, 2024 results After-Market on Nov 06, 2024
New Risk • Sep 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).
Upcoming Dividend • Sep 06Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 13 September 2024. Payment date: 01 October 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.2%).
공지 • Aug 13Albemarle Reportedly May Look to Offload 49% Stake in Greenbushes Lithium Mine to IGOSpeculation is mounting that US-based Albemarle Corporation (NYSE:ALB) may be considering selling down its 49% stake in the Greenbushes lithium mine to its Australian-listed partner IGO Limited (ASX:IGO), after the world's largest lithium producer this month slashed jobs and shut part of a processing facility in Western Australia. Greenbushes in WA is a global standout, and there is scepticism about the market chatter, although IGO wants to buy more of the asset should it be available, say sources. IGO did not comment. One reason a sale may be on the table is that Greenbushes does not qualify for the Inflation Reduction Act benefits in the US because of its partial Chinese ownership of 25.1%. To quality, Chinese ownership would need to be 24.9% or less, although the US government may show some leniency. IGO and China's Tianqi both own 51% in a joint venture arrangement. US-based lithium specialist Albemarle owns the remainder. The Australian reported last month that Albemarle, Tianqi and IGO would be taking the brakes off the giant Greenbushes mine despite low lithium prices, with the mine set to lift production over the next year as IGO intensifies its hunt for growth opportunities.
Reported Earnings • Aug 02Second quarter 2024 earnings released: US$1.96 loss per share (vs US$5.54 profit in 2Q 2023)Second quarter 2024 results: US$1.96 loss per share (down from US$5.54 profit in 2Q 2023). Revenue: US$1.43b (down 40% from 2Q 2023). Net loss: US$229.9m (down 135% from profit in 2Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
공지 • Jul 02Albemarle Corporation to Report Q2, 2024 Results on Jul 31, 2024Albemarle Corporation announced that they will report Q2, 2024 results After-Market on Jul 31, 2024
Upcoming Dividend • Jun 07Upcoming dividend of US$0.40 per shareEligible shareholders must have bought the stock before 14 June 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 58% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (5.1%).
공지 • May 03Albemarle Corporation Reaffirms Earnings Guidance for the Year 2024Albemarle Corporation reaffirmed earnings guidance for the year 2024. For the period, the company expects net sales of $5.5 billion to $6.2 billion.
Reported Earnings • May 02First quarter 2024 earnings released: US$0.078 loss per share (vs US$10.57 profit in 1Q 2023)First quarter 2024 results: US$0.078 loss per share (down from US$10.57 profit in 1Q 2023). Revenue: US$1.36b (down 47% from 1Q 2023). Net loss: US$9.14m (down 101% from profit in 1Q 2023). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
공지 • Apr 07Albemarle Corporation to Report Q1, 2024 Results on May 01, 2024Albemarle Corporation announced that they will report Q1, 2024 results After-Market on May 01, 2024
공지 • Mar 13Albemarle Corporation, Annual General Meeting, May 07, 2024Albemarle Corporation, Annual General Meeting, May 07, 2024, at 07:00 Eastern Standard Time. Location: Albemarle Corporation, 4250 Congress Street, Charlotte, North Carolina 28209, Charlotte North Carolina United States Agenda: To consider and Elect the ten nominees; to approve, on a non-binding advisory basis, the compensation of named executive officers; to approve an amendment to Albemarle's Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock; to ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.
Upcoming Dividend • Mar 07Upcoming dividend of US$0.40 per shareEligible shareholders must have bought the stock before 14 March 2024. Payment date: 01 April 2024. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (5.1%). Lower than average of industry peers (5.9%).
Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €128, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in Germany. Total returns to shareholders of 10% over the past three years.
Reported Earnings • Feb 15Full year 2023 earnings released: EPS: US$13.41 (vs US$22.97 in FY 2022)Full year 2023 results: EPS: US$13.41 (down from US$22.97 in FY 2022). Revenue: US$9.62b (up 31% from FY 2022). Net income: US$1.57b (down 42% from FY 2022). Profit margin: 16% (down from 37% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
공지 • Jan 19Albemarle Reportedly Selling Out of LiontownAlbemarle Corporation (NYSE:ALB) has appointed brokers to sell its stake in Liontown Resources Limited (ASX:LTR), three months after Hancock Prospecting effectively blocked its $6.6 billion takeover bid. JP Morgan was looking to sell Albemarle's 4% stake after the market closed, at prices ranging from $1.26 per share to $1.32 per share. With Albemarle holding 96 million Liontown shares, the deal will be worth about $125 million. The planned sale will be at a loss for Albemarle, which was understood to have acquired its stake at an average entry price of $2.35 per share. Albemarle attempted four times to acquire Liontown, which is developing the Kathleen Valley lithium mine in the Goldfields. The mine would have provided a new supply for Albemarle's downstream processing operations, including its lithium refinery at Kemerton in the South West. It lodged indicative proposals at $2.20 per share in October 2022, $2.35 in March 2023 and $2.50 later that month. It appeared to have succeeded in September when the Liontown board backed its fourth proposal - a takeover bid priced at $3 per share. However Australia's richest person, Gina Rinehart, ended the party after her private company Hancock Prospecting acquired a 19.9% blocking stake. Albemarle scrapped its takeover bid in mid-October, triggering a collapse in Liontown's share price and forcing the company to complete an equity and debt raising to ensure it could complete construction at Kathleen Valley. Hancock has retained its 19.9% stake but has been silent on its intentions.
공지 • Jan 12Albemarle Corporation to Report Q4, 2023 Results on Feb 14, 2024Albemarle Corporation announced that they will report Q4, 2023 results After-Market on Feb 14, 2024
Upcoming Dividend • Dec 07Upcoming dividend of US$0.40 per share at 1.4% yieldEligible shareholders must have bought the stock before 14 December 2023. Payment date: 02 January 2024. Payout ratio is a comfortable 5.6% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (5.2%). Lower than average of industry peers (6.0%).
공지 • Nov 18Albemarle Corporation Announces the Promotion of Cynthia Lima as Senior Vice President, Chief External Affairs and Communications OfficerAlbemarle Corporation announced that Cynthia Lima has been promoted to senior vice president, chief external affairs and communications officer. Lima joined Albemarle early in 2023 as chief communications officer and has expanded her remit to include the global external affairs function. She brings extensive government affairs and communications experience spanning both public and private sectors. Prior to joining Albemarle, Lima founded a communications and public affairs consultancy and held senior positions at domestic and global public relations agencies. Previously, Lima served in the U.S. Department of State and U.S. Department of Veterans Affairs where she was a senate-confirmed presidential appointee. Lima is based in the company's Charlotte, N.C., headquarters and will report to Masters as part of Albemarle's Executive Leadership Team.
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$2.58 (vs US$7.66 in 3Q 2022)Third quarter 2023 results: EPS: US$2.58 (down from US$7.66 in 3Q 2022). Revenue: US$2.31b (up 11% from 3Q 2022). Net income: US$302.5m (down 66% from 3Q 2022). Profit margin: 13% (down from 43% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.
공지 • Nov 02Albemarle Corporation Revises Net Sales Guidance for the Full Year 2023Albemarle Corporation revised net sales guidance for the full year 2023. For the year, the company now expects net sales to be in the range of $9.5 billion to $9.8 billion against previous guidance of $10.4 billion to $11.5 billion.
공지 • Oct 28Albemarle Corporation Announces CFO Changes, Effective on November 6, 2023Albemarle Corporation announced that Neal Sheorey will join Albemarle as its chief financial officer, effective Nov. 6, 2023. Scott Tozier, Albemarle's current chief financial officer, will transition from his current role and become a strategic advisor to the CEO. Sheorey joins Albemarle from Dow, a global materials science company, where he served for more than 20 years in progressive finance, business, and corporate leadership roles. Most recently, he was vice president of Dow's Coatings & Performance Monomers business unit, a global portfolio with more than $4 billion in sales, where he was responsible for the group's strategy, profitability, and growth initiatives. Prior to his current role, Sheorey served as Dow's vice president of investor relations, senior director of corporate development and global finance director for the Chemicals business group. Sheorey holds a master's degree in business administration with a concentration in finance and corporate strategy from the University of Michigan, and a bachelor's degree in chemical engineering from Northwestern University. Tozier joined Albemarle in 2011 as senior vice president and chief financial officer.
공지 • Oct 27Albemarle Corporation Announces Executive Changes, Effective on November 6, 2023Albemarle Corporation announced that Neal Sheorey will join Albemarle as its executive vice president, effective Nov. 6, 2023. Scott Tozier, Albemarle's current executive vice president will transition from his current role and become a strategic advisor to the CEO. Sheorey joins Albemarle from Dow, a global materials science company, where he served for more than 20 years in progressive finance, business, and corporate leadership roles. Most recently, he was vice president of Dow's Coatings & Performance Monomers business unit, a global portfolio with more than $4 billion in sales, where he was responsible for the group's strategy, profitability, and growth initiatives. Prior to his current role, Sheorey served as Dow's vice president of investor relations, senior director of corporate development and global finance director for the Chemicals business group. Sheorey holds a master's degree in business administration with a concentration in finance and corporate strategy from the University of Michigan, and a bachelor's degree in chemical engineering from Northwestern University. Tozier joined Albemarle in 2011 as senior vice president and chief financial officer.
공지 • Oct 20Albemarle Corporation (NYSE:ALB) completed the acquisition of additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN)Albemarle Corporation (NYSE:ALB) entered into binding agreement to acquire additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN) on February 23, 2023. As of July 19, 2023, Albemarle Corporation amend the terms of the transaction and agreed to acquire remaining 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources for approximately AUD 590 million ($400 million). Albemarle will supply MinRes’ 15% share of spodumene concentrate for use by Kemerton from the Greenbushes mine. MinRes will pay the benchmark price for its share of Greenbushes spodumene concentrate. In similar transaction Albemarle Corporation entered into binding agreement ownership of the Wodgina mine to change from 60% and 40% to 50% and50%. Albemarle is expected to pay MinRes a completion adjustment currently estimated to be AUD 150 million. As of July 19, 2023, upon closing, Albemarle expects to pay Mineral Resources $380 (AUD 557.5 million) - $400 million (AUD 586.9 million) which includes net consideration for the remaining 15% ownership of Kemerton as well as EED settlement adjustments. Actual settlement adjustments will depend on the date of close. The acquisition is subject to regulatory approvals. The parties anticipate closing the amended arrangements later this year. As of August 2, 2023, the transaction is expected to close in the second half of 2023. Herbert Smith Freehills LLP acted as legal advisor to Kemerton Lithium Hydroxide Plant. Albemarle Corporation (NYSE:ALB) completed the acquisition of additional 40% stake in Kemerton Lithium Hydroxide Plant from Mineral Resources Limited (ASX:MIN) on October 18, 2023.
공지 • Oct 16Albemarle Withdraws Non-Binding Offer to Acquire Liontown ResourcesOn October 15, 2023, Albemarle Corporation (NYSE:ALB) announced that it will not pursue a binding agreement to purchase Liontown Resources Limited (ASX:LTR) and has formally withdrawn its non-binding offer to Liontown's board of directors. The decision comes as Albemarle nears the end of its exclusive due diligence process. "Our engagement with the Liontown team has been meaningful and productive. We appreciate the level of cooperation we have received, and we thank the entire team for their efforts," said Kent Masters, Chief Executive Officer of Albemarle. "That said, moving forward with the acquisition, at this time, is not in Albemarle's best interests." The company noted growing complexities associated with the proposed transaction as a factor in its decision. The announcement is consistent with Albemarle's disciplined approach to capital allocation and the company will continue to execute its long-term growth strategy. Planned expansions to deliver volumetric growth continue to progress across the company's global portfolio. Albemarle's capital allocation priorities remain investing in high-return organic and inorganic growth, maintaining its financial flexibility and investment grade credit rating, and funding its dividends. Albemarle is one of Australia's biggest lithium investors, with mining assets at Wodgina and Greenbushes, and with the Kemerton lithium hydroxide plant, which is currently undergoing a significant expansion.
Board Change • Oct 13Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.